Accordingly, our results demonstrate decreased levels of NETs in synovial tissue and reduced serum anti-H3Cit antibodies in inhibitor-treated mice, clearly demonstrating that PAD4 inhibitors could be useful to impede pathogenesis in RA. This evidence concerns the gene PADI4 and rheumatoid arthritis.